You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 17.8% |
| Div Cover | n/a | -2.1 |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.1 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 1.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 5.03 | 1.63 | 1.92p | 5.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.10 | -4.10 | -3.45p | -3.8 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -4.79 | -3.53p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -17.73 | -9.46p | -16.2 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -57.86 | -24.28p | -8.6 | 0.0 | n/a | n/a | 0.0% |
| Synairgen posts positive clinical trial data for SNG001 Sharecast News | 16 May |
|---|---|
| Synairgen falls as patient recruitment halted on Covid-19 trial Sharecast News | 17 Mar |
| Synairgen asked to pause activities on Covid-19 treatment trial Sharecast News | 03 Mar |
| Full Year Results | 25-May-22 08:27 |
|---|---|
| Price Monitoring Extension | 18-May-22 16:38 |
| Synairgen presents at ATS 2022 | 16-May-22 07:00 |
| Presentation at ECCMID | 25-Apr-22 07:00 |
| Second Price Monitoring Extn | 19-Apr-22 16:43 |